TE_36606
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | LTR17 |
|---|---|
| TE superfamily | ERV1 |
| TE class | LTR |
| Gene | ENSG00000223870 |
| Class | Chimeric |
| Coding | Non-coding |
| Tumor-specific score | 156.67 |
| Counts of samples | TCGA_tumor:138; TCGA_normal:0; GTEx:0 |
| TSS | chr21(+):25118654 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_36606.1 | ENSG00000223870 | Chimeric | Non-coding | Non-coding | chr21(+):25118655,25118936,25127468,25127517,25133644,25133751,25134958,25135051,25135208,25135228 |
| teRNA_36606.2 | ENSG00000223870 | Chimeric | Non-coding | Non-coding | chr21(+):25118655,25118936,25119853,25120000,25127468,25127517,25133644,25133751,25134958,25135051,25135208,25135228 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
